1 / 8

Flow Diagram of Identification of Randomized Trials for Inclusion

Flow Diagram of Identification of Randomized Trials for Inclusion. Goran Bjelakovic, et al. JAMA. 2007;297:842-857. Characteristics of Included Trials With High Risk of Bias. Goran Bjelakovic, et al. JAMA. 2007;297:842-857. Characteristics of Included Trials With Low Risk of Bias – Part I.

colette-leach
Download Presentation

Flow Diagram of Identification of Randomized Trials for Inclusion

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Flow Diagram of Identification of Randomized Trials for Inclusion Goran Bjelakovic, et al. JAMA. 2007;297:842-857

  2. Characteristics of Included Trials With High Risk of Bias Goran Bjelakovic, et al. JAMA. 2007;297:842-857

  3. Characteristics of Included Trials With Low Risk of Bias – Part I Goran Bjelakovic, et al. JAMA. 2007;297:842-857

  4. Characteristics of Included Trials With Low Risk of Bias – Part II Goran Bjelakovic, et al. JAMA. 2007;297:842-857

  5. Participants and Outcome Measures of Included Trials With High Risk of Bias Goran Bjelakovic, et al. JAMA. 2007;297:842-857

  6. Participants and Outcome Measures of Included Trials With Low Risk of Bias P.I Goran Bjelakovic, et al. JAMA. 2007;297:842-857

  7. Participants and Outcome Measures of Included Trials With Low Risk of Bias P.II Goran Bjelakovic, et al. JAMA. 2007;297:842-857

  8. Intervention Effect of Antioxidant Supplements vs Placebo on Mortality in Trials With Low Risk of Bias Goran Bjelakovic, et al. JAMA. 2007;297:842-857

More Related